Biotechnology News

April 1, 2012

NEW YORK--(BUSINESS WIRE)--Enzo Biochem Inc. (NYSE:ENZ) announced that the Company yesterday made its first peer-reviewed presentation of its novel AmpiProbe™ platform, encompassing low cost, and high sensitivity, real time nucleic acid...

April 1, 2012

CAESAREA, Israel--(BUSINESS WIRE)--Mazor Robotics Ltd (TASE:MZOR), the leader in innovative surgical robots and complementary products for spine surgery, today announced that Florida Hospital Carrollwood, a 120-bed community hospital in Tampa, FL...

March 31, 2012

CAMBRIDGE, Mass. & CHICAGO--(BUSINESS WIRE)--Tokai Pharmaceuticals, Inc., a biopharmaceutical company focused on developing new treatments for prostate cancer, today announced that its lead candidate galeterone (TOK-001) was well-tolerated...

March 31, 2012

LONDON--(BUSINESS WIRE)--At the 22nd ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in London, Bruker announces new protocols and reference libraries for mycobacteria and multicellular fungi to further extend the...

March 31, 2012

CHALFONT ST GILES, England & BURLINGTON, Mass.--(BUSINESS WIRE)--GE Healthcare, a unit of GE (NYSE:GE), and Dyax Corp. (NASDAQ:DYAX) today announced a licensing agreement for the development and commercialization of peptides binding to c-Met...

March 31, 2012

LONDON--(BUSINESS WIRE)--At the 22nd ECCMID (European Congress of Clinical Microbiology and Infectious Diseases) in London, Bruker announces a collaboration with UMCG within the new European Network for the Rapid Identification of Anaerobes (...

March 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--PerkinElmer Highlights Innovative Solutions for Enabling Personalized Medicine in Cancer Research at AACR 2012

March 30, 2012

NEWTON, Mass.--(BUSINESS WIRE)--Galectin Therapeutics reports full year and fourth quarter 2011 financial results.

March 30, 2012

MORRISTOWN, N.J.--(BUSINESS WIRE)--QPharma, Inc., which provides consulting services to the pharma and life science industries, announces the promotion of Prajeep Kumar Thottupurath to the position of Chief Information Officer.

March 30, 2012

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Cannabis Science, Inc. (OTCBB:CBIS) a pioneering U.S. biotech company developing pharmaceutical cannabis (marijuana) products, is pleased to announce that Dr. Melamede was featured on NBC Channel 12 News...

March 30, 2012

VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: With reference to Chapter 4, Section 9 of the Swedish Financial Instruments Trading Act (SFS 1991:980), it is hereby announced that the new issue of Series B stock units during March 2012...

March 30, 2012

--(BUSINESS WIRE)--Pharmaceteutical manufacturer and distributor Company:   Taro Pharmaceutical Industries Ltd.   Headquarters Address: 14 Hakitor Street Haifa Bay 26110 Israel   Main Telephone: +97248475700   Ticker: TARO(NYSE)   Type of...

March 30, 2012

OSLO, Norway--(BUSINESS WIRE)--Regulatory News: Please find enclosed DiaGenic’s Annual Report for 2011....

March 30, 2012

MANASSAS, Va.--(BUSINESS WIRE)--ATCC, the premier biological materials resource and standards organization, announced its new depositor and material transfer agreements (MTA).

March 30, 2012

JERUSALEM--(BUSINESS WIRE)--Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announces the launch of the authorized generic of Provigil® (modafinil). Provigil® is marketed by Cephalon, Inc., a wholly owned subsidiary of Teva Pharmaceutical...

March 30, 2012

ST. LOUIS--(BUSINESS WIRE)--The American College of Rheumatology (ACR) Subcommittee on Osteoarthritis Guidelines has approved and issued several updates to clinical practice guidelines for the treatment of osteoarthritis (OA). The new guidelines...

March 30, 2012

EMERYVILLE, Calif.--(BUSINESS WIRE)--Amyris will participate in the several conferences during the second quarter of 2012.

March 30, 2012

OMAHA, Neb.--(BUSINESS WIRE)--Transgenomic, Inc. (OTCBB: TBIO) today announced that Jeana DaRe, Ph.D., Assistant CLIA Laboratory Director at Transgenomic, presented clinical findings from patients tested for nuclear mitochondrial disorders using...

March 30, 2012

AUSTIN, Texas--(BUSINESS WIRE)--Next Generation Sequencing $6.8 million commercialization award to Asuragen, Inc.

March 30, 2012

SEATTLE--(BUSINESS WIRE)--NanoString will launch 3 new products for the nCounter® Analysis System at the American Association of Cancer Research (AACR) Annual Meeting 2012: the Plex2, Cancer CNV, and Human v2 miRNA Assay Kits.

March 30, 2012

TEWKSBURY, Mass.--(BUSINESS WIRE)--Cambridge Heart, Inc. (OTCBB: CAMH), a developer of non-invasive diagnostic tests for cardiac disease, today reported results for its fourth quarter and full year ended December 31, 2011. Full financial...

March 30, 2012

ANN ARBOR, Mich.--(BUSINESS WIRE)--AlphaCore Pharma, a biopharmaceutical company, today announced the initiation of a Phase 1 study of ACP-501 (rhLCAT) in patients with stable coronary arterial disease.

March 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops targeted anticancer products, today announced that it will host a conference call at 8:00 am ET on Friday, March 30, 2012 to discuss the two...

March 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN) today announced that it has initiated Phase II testing of its IMGN901 product candidate for first-line treatment of SCLC. The Phase II assessment begun today, also known as the NORTH...

March 30, 2012

DUBLIN--(BUSINESS WIRE)--Dublin - Research and Markets (http://www.researchandmarkets....

March 30, 2012

VÄSTRA FRÖLUNDA, Sweden--(BUSINESS WIRE)--Regulatory News: Artimplant AB: (STO:ARTIB) The Annual Report for the financial year 2011 is published through this press release and on the Company's homepage:...

March 30, 2012

SOLNA, Sweden--(BUSINESS WIRE)--Regulatory News: Aerocrine: (STO:AEROB) With reference to Chapter 4 Section 9 in ”lagen (1991:980) om handel med finansiella instrument” it’s hereby announced that subscription by exercise of options in Aerocrine...

March 30, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--ImmunoGen, Inc. (Nasdaq: IMGN), a biotechnology company that develops anticancer products using its Targeted Antibody Payload (TAP) technology, today announced that Roche has announced positive topline results...

March 30, 2012

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced topline results of EMILIA, the first randomized Phase III study of trastuzumab emtansine (T-DM1). The study...

March 29, 2012

TOKYO & NEW YORK--(BUSINESS WIRE)--FUJIFILM Holdings Corporation (TSE:4901) (hereinafter: Fujifilm), a diversified technology company that operates in healthcare, highly functional materials, and document solutions, announced today the...

March 29, 2012

WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca (NYSE: AZN) today announced that the US District Court for the District of New Jersey has found the formulation patent protecting SEROQUEL XR® (quetiapine fumarate) extended release tablets to be...

March 29, 2012

PALO ALTO, Calif.--(BUSINESS WIRE)--Hercules Technology Growth Capital, Inc. (NASDAQ: HTGC), a leader in customized debt financing for entrepreneurial venture capital and private equity-backed companies in technology-related markets including...

March 29, 2012

WASHINGTON--(BUSINESS WIRE)--Sara Radcliffe, Executive Vice President of Health at the Biotechnology Industry Organization, testified today on biosimilar user fees (BsUFA) and the Prescription Drug User Fee Act (PDUFA).

March 29, 2012

N. BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc. (“Lantheus”) today announced that it will host a conference call at 4:00 p.m. ET on Thursday, April 5, 2012, to discuss its financial and operating results for the fourth...

March 29, 2012

WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. today issued financial and operational results for its fiscal fourth quarter and full fiscal year ended December 31, 2011.

March 29, 2012

WASHINGTON--(BUSINESS WIRE)--The Biotechnology Industry Organization joined other groups today in sending letters to House Armed Services Committee supporting the military's use of biofuels. Biofuels are a national security need.

March 29, 2012

HOUSTON--(BUSINESS WIRE)--Bio-Path Holdings, Inc., (OTCBB: BPTH) (“Bio-Path”), a biotechnology company developing a liposomal delivery technology for nucleic acid cancer drugs, today announced that it has entered into a services agreement with...

March 29, 2012

NASHVILLE, Tenn.--(BUSINESS WIRE)--Change Healthcare’s latest Healthcare Transparency Index examined the impact of preventive care costs and revealed significant savings opportunities for both companies and consumers.

March 29, 2012

CAMBRIDGE, Mass. & CARLSBAD, Calif.--(BUSINESS WIRE)--Genzyme, a Sanofi Company, and Isis Pharmaceuticals, announced that Genzyme has submitted an NDA to the US FDA seeking approval for KYNAMRO™ (mipomersen sodium) for the treatment of...

March 29, 2012

BAINBRIDGE, Ga. & QUINCY, Mass.--(BUSINESS WIRE)--DaniMer Scientific and Myriant announced today that the companies have formed a strategic alliance focused on delivering innovative, cost-effective bio-based materials to the marketplace. As...

March 29, 2012

ITHACA, N.Y.--(BUSINESS WIRE)--Vybion announces availability of PharmCode for partnering.

March 29, 2012

ROUND ROCK, Texas--(BUSINESS WIRE)--IDG’s Computerworld Honors Program has recognized Dell as a 2012 Laureate for its commitment of funding, employee engagement and cloud computing technology in support of childhood cancer care research globally...

March 29, 2012

ATLANTA--(BUSINESS WIRE)--Clearside Biomedical, a Georgia company developing therapeutics to treat sight-threatening diseases through a microinjection platform, announces that William (Bill) D. Humphries has joined its board.

March 29, 2012

WORCESTER, Mass.--(BUSINESS WIRE)--Agilux Laboratories is pleased to announce that Richard M. LeLacheur, Ph.D. has joined as Senior Director, Bioanalytical Operations.

March 29, 2012

SOMERSET, N.J.--(BUSINESS WIRE)--Invisible Oticon Intiga i stands up to demands of active lifestyle. Custom-made invisible-in-ear hearing device allows wearers to hear better with less effort. Stays secure during physical activity.

March 29, 2012

TORONTO--(BUSINESS WIRE)--With age comes wisdom, and today Iams is celebrating the important role senior pets play in our lives. With the help of feisty senior, Estelle Harris, Iams is launching its Senior Plus pet food – a unique formula created...

March 29, 2012

CRAIGAVON, Northern Ireland--(BUSINESS WIRE)--Almac today announced that it has signed an exclusive global distribution deal with Affymetrix, Inc. enabling them to directly sell Almac’s proprietary Xcel™ array for biomarker discovery, development...

March 29, 2012

CAMBRIDGE, Mass. & CARLSBAD, Calif.--(BUSINESS WIRE)--Genzyme, a Sanofi Company, and Isis Pharmaceuticals Inc. announced today that new two-year data from a phase 3 long-term extension study of KYNAMRO.

March 29, 2012

BOTHELL, Wash.--(BUSINESS WIRE)--Seattle Genetics, Inc. (NASDAQ:SGEN) announced today that management will present at the upcoming 11th Annual Needham Healthcare Conference in New York, NY. The presentation is scheduled for Tuesday, April 3, at...